Coherus Announces U.S. FDA Approval of YUSIMRY™ (adalimumab-aqvh)

NEXT STORY
Levitee Labs Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care throughout Alberta, Canada
PREV STORY
Cytokinetics and JI XING Announce Expansion of Collaboration to Include Licensing of Omecamtiv Mecarbil in China; RTW to Add to Its Investment in Cytokinetics
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Artificial Joints Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Type, Material, Application, End User and Geography

author_avatar
NASDAQ Market News

Basilea gibt Abschluss der Patientenrekrutierung für Phase-3-Studie ERADICATE mit Ceftobiprol bei Blutbahninfektionen bekannt

author_avatar
NASDAQ Market News

Assure Holdings Announces Update to Credit Facility

author_avatar
NASDAQ Market News